Valuation: West Pharmaceutical Services, Inc.

Market Cap 26.22B 131B 23.28B 21.79B 19.75B 37.29B 2,528B 37.56B 262B 102B 1,290B 98.44B 96.33B 4,146B P/E 2026 *
43.5x
P/E 2027 * 37.8x
Enterprise Value 25.72B 128B 22.83B 21.37B 19.37B 36.58B 2,480B 36.84B 257B 99.82B 1,265B 96.55B 94.48B 4,066B EV / Sales 2026 *
7.62x
EV / Sales 2027 * 7.04x
Free-Float
92.88%
Yield 2026 *
0.24%
Yield 2027 * 0.26%
1 day-2.36%
1 month-2.36%
3 months-6.37%
6 months+37.72%
Current year+20.83%
1 month 49.25
Extreme 49.25
49.25
Current year 34.5
Extreme 34.5
53.25
1 year 34.5
Extreme 34.5
53.25
3 years 32.64
Extreme 32.64
60
5 years 30.7
Extreme 30.7
75.51
10 years 30.7
Extreme 30.7
75.51
Manager TitleAgeSince
Chief Executive Officer 52 31/08/2026
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-.--% - - 26.51B
-1.94%-2.76%-26.60%+1.32% 173B
-1.00%0.00%-11.52%+14.41% 113B
-2.46%-0.20%-24.05%+4.65% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
+0.46%+2.85%+3.63%+72.08% 60.1B
-0.81%+6.45%+11.28%+66.17% 51.87B
-0.20%-0.92%-6.09%-31.29% 49.21B
-2.21%-3.38%-17.90%+15.57% 41.52B
-4.04%-3.75%+25.66%+0.20% 32.79B
Average -1.30%-0.32%-10.27%+14.73% 78.34B
Weighted average by Cap. -1.25%-0.47%-16.20%+11.98%

Financials

2026 *2027 *
Net sales 3.38B 16.81B 3B 2.8B 2.54B 4.8B 325B 4.83B 33.67B 13.1B 166B 12.67B 12.4B 534B 3.59B 17.86B 3.18B 2.98B 2.7B 5.1B 346B 5.14B 35.79B 13.92B 176B 13.46B 13.18B 567B
Net income 621M 3.09B 552M 516M 468M 884M 59.91B 890M 6.2B 2.41B 30.56B 2.33B 2.28B 98.25B 710M 3.54B 630M 590M 535M 1.01B 68.46B 1.02B 7.09B 2.76B 34.92B 2.67B 2.61B 112B
Net Debt -503M -2.51B -447M -418M -379M -716M -48.51B -721M -5.02B -1.95B -24.75B -1.89B -1.85B -79.56B -973M -4.85B -864M -809M -733M -1.38B -93.84B -1.39B -9.71B -3.78B -47.87B -3.65B -3.58B -154B
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
372.64USD
Average target price
411.00USD
Spread / Average Target
+10.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - West Pharmaceutical Services, Inc.